About our
Quality Policy

Quality Policy

Integrated Management System

Our Quality Policy is focused on business continuity. For NimaGen, its employees, customers, and business partners. We are convinced that the ability of the NimaGen organisation to maintain essential functions can only be warranted when environmental protection and sustainability, good and safe working conditions, organizational learning, high quality standards, and organizational alignment are an integral part of the total enterprise. To support this, all aspects of the organisation's systems, processes and standards are combined into our Integrated Management System (IMS).

 

NimaGen is committed to increased performance, employee and customer satisfaction, and continuous improvement. The IMS coordinated, systemic effort allows us to streamline our process management, eliminate error, mitigate risks, and increase efficiency and effectiveness by addressing all elements of the management system as a whole, while minimizing the disruption caused by external audits. Our regularly maintained and frequently audited IMS is driven by the following guiding principles: Quality and Improvement.

Quality

Customer Satisfaction

NimaGen, part of the Dutch Biolegio Holding and founded in 2011, is a well-recognized manufacturer and provider of high-quality reagents for Sanger Sequencing and Fragment Analysis (Capillary Electrophoresis) and Next-generation Sequencing (NGS), used by molecular biology laboratories around the world.

 

The ability of these laboratories to provide consistent and reliable results to their customers depends on the consistent supply of high-quality reagents over time. Evaluating NimaGen manufacturing capability requires an understanding of how we manage and control our manufacturing operations to ensure your product is delivered on time and to your specifications every time. 

 

We believe our reagent products and services must meet your expectations and, even better, should surpass these expectations. To achieve this goal, our integrated R&D, production, quality control, sales and customer service process is monitored and controlled under recognized ISO 9000 and ISO 13485 quality management system certification. NimaGen sites and departments engage in continuous improvement of these quality programs.

 

BSI

Improvement

Striving for Excellence

We believe that building a high level of quality and customer satisfaction is based on a collaborative approach, pivotal in warranting a continued flow of improved and novel products and associated services to the laboratory science community. Feedback from both you and our staff on this subject is very much appreciated.

 

Each business year, our management team will determine concrete, measurable key performance indicators (KPIs) relative to the expectations of both our customers and staff, as well as other business objectives. Performance and progress are monitored and frequently evaluated against these pre-determined KPIs, to assess how effectively business objectives are met, or may require appropriate and effective follow-up. 

 

NimaGen strives to excel in all its undertakings, our IMS set up to meet the highest requirements for audit and certification of quality management. While complying with all relevant regulatory, legal, business and contractual security obligations, we will ensure that any risks, threats and vulnerabilities associated with our business are adequately identified, assessed and mitigated. Similarly, we will identify and embrace any opportunity that would be beneficial to our company and our valued customers.
 

Ruud van der Steen                    
CEO NimaGen                            

 

 

 

News

Latest news

News | 27.02.24

BSM 2024 (Belgian Society for Microbiology) Attendance Announcement

Come meet the NimaGen team on March 8th, 2024 in Brussels, Belgium to learn all about the Next Revolution in Microbial NGS! We offer a full workflow solution for Sanger Sequencing and Fragment Analysis, as well as Reverse Complement PCR powered EasySeq™ NGS Library Prep kits for Bacterial Identification (V1-V9) or Microbiome (V3, V4) 16S rRNA analysis on illumina® or Full-Length 16S on Oxford Nanopore Technologies (ONT) platforms.
News | 08.01.24

NimaGen's 2023 Highlights ReCAPPed!

NimaGen had a great 2023 and were looking forward to an even better 2024!    NimaGen’s 2023 ReCAPPed™ (Yes, this a pun on our product name):  Our New Building and Facilities:  We kicked off 2023 by moving into our new building with state-of-the-art laboratory and production spaces, as well as comfortable office and meeting spaces! Our NimaGen Grand Opening party in May was an exciting event celebrated by all to commemorate such a momentous occasion; it was also attended by our local major of Nijmegen!            Our New Reverse Complement PCR Sequencing Kits:  From there, we spent the year developing several innovative and exciting new Reverse-Complement PCR sequencing kits for our application areas in Forensics, Microbiology and Infectious Disease and Human Genetics!      Distributors, Partnerships and Collaborations In 2023, NimaGen gained 15 partnerships around the world that help support our expanding product portfolio! From the far reaches of Barcode Biosciences in India to our neighboring country France supported by Dominique Dutscher SAS, as well as strategic collaborations with partnerships in North American with NicheVision for our Forensics portfolio, we desire to help our customers in every cornerstone of the world. Together, we will continue creating shared value!    Customer Experience Survey Rating At the end of 2023, active NimaGen customers received a customer experience survey with an average score of >8/10!. NimaGen responsiveness, solutions focus, personal interaction and product value were highly rated by both customers and distributors. We are grateful for the feedback we received and will continue to strive to continue improve our customer service, quality products and continued innovation that supports  research globally!    Continued ISO 90001 and 13485 Certification  NimaGen proudly continues to maintain its ISO 90001 and ISO 13485 certification. ISO 90001 is a globally recognized standard for quality management that ensures high-level customer service, ongoing optimization and continued process improvement. ISO 13485 is an international standard that specifies strict requirements for quality and competence in a medical device organization, including biotechnology companies, thus ensuring that we are providing high-quality reagents and products.  Congress and Event Attendance:  NimaGen attended several events around the world in 2023! Some conferences were local to the Netherlands such as Dutch Society of Medical Microbiology and the Royal Dutch Society of Microbiology (KNVM NVMM)  or our very own NimaGen Distributor Meeting here in Nijmegen! Other conferences were  within Europe, such as European Society of Clinical Microbiology and Infectious Diseases (ECCMID) in Denmark and the European Society of Human Genetics (ESHG) in Scotland. We also attended many international ones such as International Association of Forensic Sciences (IAFS) in Australia and the International Symposium on Human Identification (ISHI) for Forensics and the American Society for Human Genetics (ASHG) in the U.S.A!  Local: KNVM NVMM 2023 – Arnhem, The Netherlands    NimaGen Distributor Meeting 2023 - Creating Shared Value with our Partners  Europe: ECCMID 2023 – Copenhagen, Denmark   ESHG 2023 – Edinburgh, Scotland    International: IAFS 2023 – Sydney, Australia         ISHI 2023 – Denver, CO USA ASHG 2023 – Washington, D.C. USA             
News | 12.12.23

PT. Indolab Utama (Indonesia): Welcome to the NimaGen Distributor Network!

NimaGen is happy to announce the collaboration with @PT. Indolab Utama. Indolab Utama focusses on Research Institutes, Food and Beverage Industry, Pharmaceutical Industry, Hospital and Universities in the Indonesian market. They have supported several NimaGen users for some time already and we have now strengthened the partnership with an official distributorship. We look forward to working with Indolab Utama to support the customers in Indonesia better.